Profile Solutions, Inc.
Profile Solutions, Inc. PSIQ Peers
See (PSIQ) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PSIQ | $0.00 | +4900.00% | 38735.00 | N/A | N/A | N/A |
| MKKGY | $25.68 | -1.68% | 60.36B | 17.96 | $1.43 | +1.47% |
| MKGAF | $128.11 | -2.39% | 55.70B | 17.92 | $7.15 | +1.70% |
| HLNCF | $5.39 | +0.94% | 48.62B | 25.67 | $0.21 | +1.99% |
| TKPHF | $26.30 | -18.15% | 41.39B | 58.44 | $0.45 | +5.06% |
| IPSEY | $28.55 | +0.25% | 37.78B | 23.99 | $1.19 | +1.11% |
| SDZNY | $46.68 | +1.58% | 20.10B | -2333.90 | -$0.02 | +0.88% |
| TEVJF | $16.11 | N/A | 18.46B | -14.01 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOF | $15.20 | N/A | 12.93B | 11.26 | $1.35 | +2.74% |
Stock Comparison
PSIQ vs MKKGY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, MKKGY has a market cap of 60.36B. Regarding current trading prices, PSIQ is priced at $0.00, while MKKGY trades at $25.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 17.96. In terms of profitability, PSIQ's ROE is -1.73%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, PSIQ is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs MKGAF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, MKGAF has a market cap of 55.70B. Regarding current trading prices, PSIQ is priced at $0.00, while MKGAF trades at $128.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.92. In terms of profitability, PSIQ's ROE is -1.73%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, PSIQ is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HLNCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HLNCF has a market cap of 48.62B. Regarding current trading prices, PSIQ is priced at $0.00, while HLNCF trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 25.67. In terms of profitability, PSIQ's ROE is -1.73%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, PSIQ is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TKPHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TKPHF has a market cap of 41.39B. Regarding current trading prices, PSIQ is priced at $0.00, while TKPHF trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 58.44. In terms of profitability, PSIQ's ROE is -1.73%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, PSIQ is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs IPSEY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, IPSEY has a market cap of 37.78B. Regarding current trading prices, PSIQ is priced at $0.00, while IPSEY trades at $28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 23.99. In terms of profitability, PSIQ's ROE is -1.73%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, PSIQ is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SDZNY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SDZNY has a market cap of 20.10B. Regarding current trading prices, PSIQ is priced at $0.00, while SDZNY trades at $46.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is -2333.90. In terms of profitability, PSIQ's ROE is -1.73%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, PSIQ is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TEVJF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, PSIQ is priced at $0.00, while TEVJF trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, PSIQ's ROE is -1.73%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, PSIQ is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ESALY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, PSIQ is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, PSIQ's ROE is -1.73%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, PSIQ is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SGIOF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, PSIQ is priced at $0.00, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 11.26. In terms of profitability, PSIQ's ROE is -1.73%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, PSIQ is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SGIOY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SGIOY has a market cap of 12.91B. Regarding current trading prices, PSIQ is priced at $0.00, while SGIOY trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 11.16. In terms of profitability, PSIQ's ROE is -1.73%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, PSIQ is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs BIOVF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, PSIQ is priced at $0.00, while BIOVF trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 26.29. In terms of profitability, PSIQ's ROE is -1.73%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, PSIQ is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs IPSEF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, PSIQ is priced at $0.00, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 25.96. In terms of profitability, PSIQ's ROE is -1.73%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, PSIQ is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SFOSF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SFOSF has a market cap of 8.72B. Regarding current trading prices, PSIQ is priced at $0.00, while SFOSF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 12.97. In terms of profitability, PSIQ's ROE is -1.73%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, PSIQ is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ESALF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ESALF has a market cap of 7.34B. Regarding current trading prices, PSIQ is priced at $0.00, while ESALF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 23.42. In terms of profitability, PSIQ's ROE is -1.73%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, PSIQ is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ESAIY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ESAIY has a market cap of 7.19B. Regarding current trading prices, PSIQ is priced at $0.00, while ESAIY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 22.76. In terms of profitability, PSIQ's ROE is -1.73%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, PSIQ is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs GZPHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, GZPHF has a market cap of 6.31B. Regarding current trading prices, PSIQ is priced at $0.00, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, PSIQ's ROE is -1.73%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, PSIQ is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HKMPY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HKMPY has a market cap of 6.20B. Regarding current trading prices, PSIQ is priced at $0.00, while HKMPY trades at $56.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 17.47. In terms of profitability, PSIQ's ROE is -1.73%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, PSIQ is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HKMPF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HKMPF has a market cap of 5.94B. Regarding current trading prices, PSIQ is priced at $0.00, while HKMPF trades at $26.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 16.73. In terms of profitability, PSIQ's ROE is -1.73%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, PSIQ is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs APNHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, PSIQ is priced at $0.00, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 20.07. In terms of profitability, PSIQ's ROE is -1.73%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, PSIQ is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs WIBFF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, WIBFF has a market cap of 4.91B. Regarding current trading prices, PSIQ is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, PSIQ's ROE is -1.73%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, PSIQ is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HLBBF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HLBBF has a market cap of 4.04B. Regarding current trading prices, PSIQ is priced at $0.00, while HLBBF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 10.62. In terms of profitability, PSIQ's ROE is -1.73%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, PSIQ is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LVZPF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LVZPF has a market cap of 4.02B. Regarding current trading prices, PSIQ is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, PSIQ's ROE is -1.73%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, PSIQ is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HLUBF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HLUBF has a market cap of 3.46B. Regarding current trading prices, PSIQ is priced at $0.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, PSIQ's ROE is -1.73%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, PSIQ is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs INVVY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, PSIQ is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, PSIQ's ROE is -1.73%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, PSIQ is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs APNHY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, APNHY has a market cap of 2.92B. Regarding current trading prices, PSIQ is priced at $0.00, while APNHY trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 11.94. In terms of profitability, PSIQ's ROE is -1.73%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, PSIQ is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs IZQVF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, PSIQ is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, PSIQ's ROE is -1.73%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, PSIQ is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HMDCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, PSIQ is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, PSIQ's ROE is -1.73%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, PSIQ is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HYPMY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HYPMY has a market cap of 2.71B. Regarding current trading prices, PSIQ is priced at $0.00, while HYPMY trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 19.50. In terms of profitability, PSIQ's ROE is -1.73%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, PSIQ is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs DNPUF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, PSIQ is priced at $0.00, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 16.33. In terms of profitability, PSIQ's ROE is -1.73%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, PSIQ is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ULIHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, PSIQ is priced at $0.00, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, PSIQ is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HTSUF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HTSUF has a market cap of 2.41B. Regarding current trading prices, PSIQ is priced at $0.00, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.59. In terms of profitability, PSIQ's ROE is -1.73%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, PSIQ is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs THCBF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, THCBF has a market cap of 2.35B. Regarding current trading prices, PSIQ is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -0.10. In terms of profitability, PSIQ's ROE is -1.73%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, PSIQ is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CHSYF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, PSIQ is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, PSIQ's ROE is -1.73%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, PSIQ is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TSMRF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, PSIQ is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, PSIQ's ROE is -1.73%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, PSIQ is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs DMPHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, PSIQ is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 16.76. In terms of profitability, PSIQ's ROE is -1.73%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, PSIQ is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LJUIF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, PSIQ is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, PSIQ's ROE is -1.73%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, PSIQ is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LBTSF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, PSIQ is priced at $0.00, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, PSIQ's ROE is -1.73%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, PSIQ is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs NPNKF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, NPNKF has a market cap of 1.76B. Regarding current trading prices, PSIQ is priced at $0.00, while NPNKF trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 7.98. In terms of profitability, PSIQ's ROE is -1.73%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, PSIQ is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SHEZF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SHEZF has a market cap of 1.69B. Regarding current trading prices, PSIQ is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, PSIQ's ROE is -1.73%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, PSIQ is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CHIZF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, PSIQ is priced at $0.00, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, PSIQ's ROE is -1.73%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, PSIQ is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SMDPY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, PSIQ is priced at $0.00, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is -1.32. In terms of profitability, PSIQ's ROE is -1.73%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, PSIQ is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs NPPNY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, NPPNY has a market cap of 1.54B. Regarding current trading prices, PSIQ is priced at $0.00, while NPPNY trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 6.98. In terms of profitability, PSIQ's ROE is -1.73%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, PSIQ is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs KARBF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, PSIQ is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, PSIQ's ROE is -1.73%, compared to KARBF's ROE of N/A. Regarding short-term risk, PSIQ is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs YIHCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, YIHCF has a market cap of 1.47B. Regarding current trading prices, PSIQ is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, PSIQ is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs EVOTF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, PSIQ is priced at $0.00, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, PSIQ's ROE is -1.73%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, PSIQ is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ARSUF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, PSIQ is priced at $0.00, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, PSIQ's ROE is -1.73%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, PSIQ is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs GTBIF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, GTBIF has a market cap of 1.33B. Regarding current trading prices, PSIQ is priced at $0.00, while GTBIF trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 26.72. In terms of profitability, PSIQ's ROE is -1.73%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, PSIQ is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SWGHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SWGHF has a market cap of 1.15B. Regarding current trading prices, PSIQ is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 16.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, PSIQ is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs GNMLF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, PSIQ is priced at $0.00, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, PSIQ's ROE is -1.73%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, PSIQ is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs KKPCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, KKPCF has a market cap of 1.01B. Regarding current trading prices, PSIQ is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 7.10. In terms of profitability, PSIQ's ROE is -1.73%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, PSIQ is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs BIOGY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, BIOGY has a market cap of 997.98M. Regarding current trading prices, PSIQ is priced at $0.00, while BIOGY trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.87. In terms of profitability, PSIQ's ROE is -1.73%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, PSIQ is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs KSPHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, PSIQ is priced at $0.00, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 12.49. In terms of profitability, PSIQ's ROE is -1.73%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, PSIQ is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CASBF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CASBF has a market cap of 987.94M. Regarding current trading prices, PSIQ is priced at $0.00, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -15.24. In terms of profitability, PSIQ's ROE is -1.73%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, PSIQ is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LVTTF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LVTTF has a market cap of 878.44M. Regarding current trading prices, PSIQ is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, PSIQ's ROE is -1.73%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, PSIQ is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs EVRRF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, EVRRF has a market cap of 875.16M. Regarding current trading prices, PSIQ is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, PSIQ's ROE is -1.73%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, PSIQ is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TCNNF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TCNNF has a market cap of 842.65M. Regarding current trading prices, PSIQ is priced at $0.00, while TCNNF trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -5.58. In terms of profitability, PSIQ's ROE is -1.73%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, PSIQ is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs NRXCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, NRXCF has a market cap of 830.40M. Regarding current trading prices, PSIQ is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, PSIQ's ROE is -1.73%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, PSIQ is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TWAPF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, PSIQ is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.35. In terms of profitability, PSIQ's ROE is -1.73%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, PSIQ is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CSWYF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, PSIQ is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, PSIQ's ROE is -1.73%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, PSIQ is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TRXPF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, PSIQ is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, PSIQ's ROE is -1.73%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, PSIQ is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CURLF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CURLF has a market cap of 684.52M. Regarding current trading prices, PSIQ is priced at $0.00, while CURLF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -2.75. In terms of profitability, PSIQ's ROE is -1.73%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, PSIQ is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SWDCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, PSIQ is priced at $0.00, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, PSIQ's ROE is -1.73%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, PSIQ is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs NIKA Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, NIKA has a market cap of 672.83M. Regarding current trading prices, PSIQ is priced at $0.00, while NIKA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, PSIQ's ROE is -1.73%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, PSIQ is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs TRSSF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, PSIQ is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, PSIQ's ROE is -1.73%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, PSIQ is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ELTP Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ELTP has a market cap of 586.48M. Regarding current trading prices, PSIQ is priced at $0.00, while ELTP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -27.45. In terms of profitability, PSIQ's ROE is -1.73%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, PSIQ is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CCHWF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, PSIQ is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, PSIQ's ROE is -1.73%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, PSIQ is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SGFEF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SGFEF has a market cap of 509.44M. Regarding current trading prices, PSIQ is priced at $0.00, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 23.30. In terms of profitability, PSIQ's ROE is -1.73%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, PSIQ is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs AIHLF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, PSIQ is priced at $0.00, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, PSIQ's ROE is -1.73%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, PSIQ is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs BOIRF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, PSIQ is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, PSIQ's ROE is -1.73%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, PSIQ is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs PEXXF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, PSIQ is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to PEXXF's ROE of N/A. Regarding short-term risk, PSIQ is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs SHPHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, SHPHF has a market cap of 455.30M. Regarding current trading prices, PSIQ is priced at $0.00, while SHPHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -1.64. In terms of profitability, PSIQ's ROE is -1.73%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, PSIQ is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs MITPF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, PSIQ is priced at $0.00, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -3.05. In terms of profitability, PSIQ's ROE is -1.73%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, PSIQ is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs KHTRF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, KHTRF has a market cap of 443.54M. Regarding current trading prices, PSIQ is priced at $0.00, while KHTRF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 63.71. In terms of profitability, PSIQ's ROE is -1.73%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, PSIQ is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs AGYTF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, PSIQ is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, PSIQ's ROE is -1.73%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, PSIQ is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs GLASF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, GLASF has a market cap of 318.23M. Regarding current trading prices, PSIQ is priced at $0.00, while GLASF trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -29.40. In terms of profitability, PSIQ's ROE is -1.73%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, PSIQ is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs PKBFF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, PKBFF has a market cap of 285.89M. Regarding current trading prices, PSIQ is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, PSIQ is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs BHCCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, PSIQ is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, PSIQ's ROE is -1.73%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, PSIQ is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs VRNOF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, VRNOF has a market cap of 241.01M. Regarding current trading prices, PSIQ is priced at $0.00, while VRNOF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -0.67. In terms of profitability, PSIQ's ROE is -1.73%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, PSIQ is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CRLBF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CRLBF has a market cap of 229.21M. Regarding current trading prices, PSIQ is priced at $0.00, while CRLBF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -3.09. In terms of profitability, PSIQ's ROE is -1.73%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, PSIQ is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CPHRF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CPHRF has a market cap of 228.73M. Regarding current trading prices, PSIQ is priced at $0.00, while CPHRF trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 24.81. In terms of profitability, PSIQ's ROE is -1.73%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, PSIQ is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs PLNHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, PSIQ is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, PSIQ's ROE is -1.73%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, PSIQ is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HUMDF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, PSIQ is priced at $0.00, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, PSIQ's ROE is -1.73%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, PSIQ is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs COPHF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, PSIQ is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, PSIQ's ROE is -1.73%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, PSIQ is more volatile compared to COPHF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs STMH Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, STMH has a market cap of 123.78M. Regarding current trading prices, PSIQ is priced at $0.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas STMH's P/E ratio is N/A. In terms of profitability, PSIQ's ROE is -1.73%, compared to STMH's ROE of -2.75%. Regarding short-term risk, PSIQ is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs PHCUF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, PHCUF has a market cap of 115.12M. Regarding current trading prices, PSIQ is priced at $0.00, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 432.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, PSIQ is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LPCUF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, PSIQ is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, PSIQ's ROE is -1.73%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, PSIQ is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CNVCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, PSIQ is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, PSIQ is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs HLTRF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, PSIQ is priced at $0.00, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -5.65. In terms of profitability, PSIQ's ROE is -1.73%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, PSIQ is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs GRUSF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, GRUSF has a market cap of 96.91M. Regarding current trading prices, PSIQ is priced at $0.00, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is -7.82. In terms of profitability, PSIQ's ROE is -1.73%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, PSIQ is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs BIOYF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, BIOYF has a market cap of 96.36M. Regarding current trading prices, PSIQ is priced at $0.00, while BIOYF trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 19.09. In terms of profitability, PSIQ's ROE is -1.73%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, PSIQ is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs ABSCF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, PSIQ is priced at $0.00, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -20.00. In terms of profitability, PSIQ's ROE is -1.73%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, PSIQ is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs CBWTF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, CBWTF has a market cap of 84.43M. Regarding current trading prices, PSIQ is priced at $0.00, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is -6.43. In terms of profitability, PSIQ's ROE is -1.73%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, PSIQ is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LOVFF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LOVFF has a market cap of 83.55M. Regarding current trading prices, PSIQ is priced at $0.00, while LOVFF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 9.22. In terms of profitability, PSIQ's ROE is -1.73%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, PSIQ is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs GBLP Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, PSIQ is priced at $0.00, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas GBLP's P/E ratio is -0.67. In terms of profitability, PSIQ's ROE is -1.73%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, PSIQ is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs LRDSF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, LRDSF has a market cap of 82.72M. Regarding current trading prices, PSIQ is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, PSIQ's ROE is -1.73%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, PSIQ is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs PLNH Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, PLNH has a market cap of 81.05M. Regarding current trading prices, PSIQ is priced at $0.00, while PLNH trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas PLNH's P/E ratio is -1.56. In terms of profitability, PSIQ's ROE is -1.73%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, PSIQ is more volatile compared to PLNH. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs EOFBY Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, PSIQ is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, PSIQ's ROE is -1.73%, compared to EOFBY's ROE of N/A. Regarding short-term risk, PSIQ is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs AAWH Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, AAWH has a market cap of 63.36M. Regarding current trading prices, PSIQ is priced at $0.00, while AAWH trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.77. In terms of profitability, PSIQ's ROE is -1.73%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, PSIQ is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.
PSIQ vs MEDXF Comparison
PSIQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PSIQ stands at 38735.00. In comparison, MEDXF has a market cap of 62.10M. Regarding current trading prices, PSIQ is priced at $0.00, while MEDXF trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PSIQ currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is 12.83. In terms of profitability, PSIQ's ROE is -1.73%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, PSIQ is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for PSIQ.